Stable incidence and continued improvement in short term mortality of Staphylococcus aureus bacteraemia between 1995 and 2008
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Stable incidence and continued improvement in short term mortality of Staphylococcus aureus bacteraemia between 1995 and 2008 ; volume:12 ; number:1 ; day:17 ; month:10 ; year:2012 ; pages:1-7 ; date:12.2012
BMC infectious diseases ; 12, Heft 1 (17.10.2012), 1-7, 12.2012
- Beteiligte Personen und Organisationen
-
Mejer, Niels
Westh, Henrik
Schønheyder, Henrik C.
Jensen, Allan G.
Larsen, Anders R.
Skov, Robert
Benfield, Thomas
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-12-260
- URN
-
urn:nbn:de:1111-201603033369
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mejer, Niels
- Westh, Henrik
- Schønheyder, Henrik C.
- Jensen, Allan G.
- Larsen, Anders R.
- Skov, Robert
- Benfield, Thomas
- SpringerLink (Online service)
Ähnliche Objekte (12)
Clinical significance of concomitant bacteriuria in patients with Staphylococcus aureus bacteraemia
Methicillin-resistant Staphylococcus aureus (MRSA) catheter-related bacteraemia in haemodialysis patients
Infection characteristics and treatment of Staphylococcus aureus bacteraemia at a tertiary children’s hospital
Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus
Genomic exploration of sequential clinical isolates reveals a distinctive molecular signature of persistent Staphylococcus aureus bacteraemia
Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial
Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial
Whole genome sequencing and molecular epidemiology of methicillin-resistant Staphylococcus aureus isolated from patients with bacteraemia in Slovenia
Methicillin-sensitive Staph. aureus (MSSA) and methicillin-resistant Staph. aureus (MRSA) bacteraemia decline simulaneously
Exploring the virulence potential of Staphylococcus aureus CC121 and CC152 lineages related to paediatric community-acquired bacteraemia in Manhiça, Mozambique
Correction to: Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial
Clinical significance of concomitant bacteriuria in patients with Staphylococcus aureus bacteraemia
Methicillin-resistant Staphylococcus aureus (MRSA) catheter-related bacteraemia in haemodialysis patients
Infection characteristics and treatment of Staphylococcus aureus bacteraemia at a tertiary children’s hospital
Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus
Genomic exploration of sequential clinical isolates reveals a distinctive molecular signature of persistent Staphylococcus aureus bacteraemia
Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial
Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial
Whole genome sequencing and molecular epidemiology of methicillin-resistant Staphylococcus aureus isolated from patients with bacteraemia in Slovenia
Methicillin-sensitive Staph. aureus (MSSA) and methicillin-resistant Staph. aureus (MRSA) bacteraemia decline simulaneously
Exploring the virulence potential of Staphylococcus aureus CC121 and CC152 lineages related to paediatric community-acquired bacteraemia in Manhiça, Mozambique
Correction to: Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial
Clinical significance of concomitant bacteriuria in patients with Staphylococcus aureus bacteraemia
Methicillin-resistant Staphylococcus aureus (MRSA) catheter-related bacteraemia in haemodialysis patients
Infection characteristics and treatment of Staphylococcus aureus bacteraemia at a tertiary children’s hospital
Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus
Genomic exploration of sequential clinical isolates reveals a distinctive molecular signature of persistent Staphylococcus aureus bacteraemia
Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial
Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial
Whole genome sequencing and molecular epidemiology of methicillin-resistant Staphylococcus aureus isolated from patients with bacteraemia in Slovenia
Methicillin-sensitive Staph. aureus (MSSA) and methicillin-resistant Staph. aureus (MRSA) bacteraemia decline simulaneously
Exploring the virulence potential of Staphylococcus aureus CC121 and CC152 lineages related to paediatric community-acquired bacteraemia in Manhiça, Mozambique